Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=15766008&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Reduced-intensity conditioning regimens in malignant haematological diseases Buffart TE; Janssen JJ; Huijgens PCNeth J Med 2005[Feb]; 63 (2): 43-51Allogeneic stem cell transplantation is a potentially curative procedure for patients with haematological malignancies. Conventional, myeloablative conditioning is, however, poorly tolerated by patients of advanced age, those receiving second transplants and those with concomitant diseases. Based on recognition of the importance of a graft-versus-disease (GVD) effect in curing malignant haematological disease, reduced intensity conditioning (RIC) as preparation for allogeneic stem cell transplantation has been developed for these patients. Although large prospective randomised clinical trials with significant follow-up are lacking, transplant-related morbidity and mortality of RIC transplants seem to compare favourably with conventional conditioning in this group of patients.|Antineoplastic Combined Chemotherapy Protocols/*therapeutic use[MESH]|Combined Modality Therapy[MESH]|Female[MESH]|Graft Rejection[MESH]|Graft Survival[MESH]|Hematologic Neoplasms/mortality/pathology/*therapy[MESH]|Hematopoietic Stem Cell Transplantation/adverse effects/*methods[MESH]|Humans[MESH]|Male[MESH]|Prognosis[MESH]|Randomized Controlled Trials as Topic[MESH]|Risk Assessment[MESH]|Severity of Illness Index[MESH]|Survival Analysis[MESH]|Transplantation Conditioning/*methods[MESH] |